Overview

Effects of Single Oral Dose Dapagliflozin QT Study

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to examine the effect of dapagliflozin on electronic measures of heart beats in healthy males
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Bristol-Myers Squibb
Treatments:
Dapagliflozin
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination